(“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders and associated chronic health ...

Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has ...

More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...

Researchers believe that a drug used to treat childhood epilepsy may also be good for assisting with sleep apnea-related ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Nearly a quarter of people in a global analysis of Samsung Health users showed indicators associated with sleep apnea risk, highlighting how widespread the underdiagnosed sleep disorder may be, ...

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

Most hypnotics (sleep medications) for insomnia (sleep disorder) do not worsen obstructive sleep apnea but emphasize the need ...

A centuries-old tradition may soon find a place in modern medicine. Researchers have discovered that a simple breathing exercise involving a conch shell can ease symptoms of a common sleep disorder.

The American Transportation Research Institute on April 15 launched an online survey of truck drivers on issues related to sleep apnea. ATRI said the survey results will be combined with other sleep ...

Incannex Healthcare Limited shares are tumbling on Thursday as the company announced a registered direct offering of $10 ...